Microbial products and their effects on the patient. Version 1 COVID 19
Research type
Research Study
Full title
The detection of microbial products and the effects on patients in infection COVID 19
IRAS ID
162013
Contact name
Becky Ward
Contact email
Sponsor organisation
Imperial College London
Research summary
Can bacterial products be detected in body fluids or tissues during infection?\nBacteria produce a number of exoproteins that can be detected during broth growth, and we seek to identify them now in clinical infection.[COVID-19 amendment – 03/04/2020] Intention of project is to include samples from patients with COVID19 as well as other acute infections hence terminology is altered to reflect this (“bacterial“ changed to “microbial“). 2.Amendment requested to allow sharing of samples with Imperial colleagues to undertake work detailed in protocol. \n3. New end date requested (31st March 2025)- new funding obtained via NIHR HPRU in AMR and HCAI awarded April 2020 for 5 years
REC name
London - West London & GTAC Research Ethics Committee
REC reference
06/Q0406/20
Date of REC Opinion
26 Apr 2006
REC opinion
Favourable Opinion